December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Fine-Needle Aspiration Biopsy of Solid Intraocular Tumors in Patients who Requested Biopsy Prior to Consenting to Recommended Treatment
Author Affiliations & Notes
  • JJ Augsburger
    University of Cincinnati Cincinnati OH
  • S Schneider
    University of Cincinnati Cincinnati OH
    Ophthalmology and Pathology & Laboratory Medicine
  • ZM Correa
    Ophthalmology ISCMPA-Santa Casa Porto Alegre Brazil
  • RS Yassin
    Pathology & Laboratory Medicine
    University of Cincinnati Cincinnati OH
  • TM Robinson-Smith
    Department of Pathology
    University of Cincinnati Cincinnati OH
  • H Ehya
    Pathology Fox Chase Cancer Center Philadelphia PA
  • N Trichopoulos
    University of Cincinnati Cincinnati OH
  • Footnotes
    Commercial Relationships   J.J. Augsburger, None; S. Schneider, None; Z.M. Correa, None; R.S. Yassin, None; T.M. Robinson-Smith, None; H. Ehya, None; N. Trichopoulos, None. Grant Identification: RPB Challenge Grant
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1157. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JJ Augsburger, S Schneider, ZM Correa, RS Yassin, TM Robinson-Smith, H Ehya, N Trichopoulos; Fine-Needle Aspiration Biopsy of Solid Intraocular Tumors in Patients who Requested Biopsy Prior to Consenting to Recommended Treatment . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1157.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To summarize the results of fine-needle aspiration biopsy (FNAB) of solid intraocular tumors in patients with an unequivocal clinical diagnosis of malignant intraocular neoplasm who requested (or whose parents requested) pathologic confirmation of the diagnosis by biopsy prior to consenting to treatment. Methods: Retrospective descriptive clinical study of 50 patients who underwent FNAB of a solid intraocular tumor in response to patient request for pathologic confirmation of our clinical diagnosis prior to planned treatment. The pre-biopsy clinical diagnosis was uveal melanoma in 46, lymphoma in 2, and retinoblastoma in 2. Results: FNAB yielded a sufficient aspirate for reliable cytodiagnosis in 48 of the 50 patients (96.0%). Cytopathologic study confirmed the pre-biopsy clinical diagnosis in all 48. These 48 patients were subsequently treated by the method recommended prior to FNAB. The two tumors that yielded an insufficient aspirate for cytodiagnosis were felt to be primary uveal melanomas. Both were relatively thin (each 2.7 mm in maximal thickness by A-scan biometry) in comparison with the tumors in the group as a whole (mean thickness 5.1 mm). After being informed about the inconclusive results, both of these patients consented to the treatment that had been recommended prior to FNAB. Enucleation was the selected method of treatment for 27 of the 50 affected eyes. The cytopathologic diagnosis was uveal melanoma in 26 of these eyes and retinoblastoma in 1. Histopathologic study confirmed the cytopathologic diagnosis in 26 of the 27 cases. One case diagnosed as an amelanotic spindle cell melanoma by cytopathology proved to be an isolated retinal astrocytoma by histopathology. The FNAB-derived tumor aspirate in this case was too scant to allow immunohistochemical staining that might have avoided this misdiagnosis. Conclusion: In patients with an unequivocal diagnosis of malignant intraocular neoplasm, FNAB provides a sufficient aspirate to confirm the clinical diagnosis in the great majority of cases. Erroneous cytopathologic diagnosis is possible in cases that yield an insufficient aspirate for immunocytochemical staining studies.

Keywords: 507 pathology: human • 496 oncology • 464 melanoma 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.